A synthetic form of this peptide, called Exenatide, was the first incretin analog approved by the US FDA to treat diabetes
doi: 10.1084/jem.20050749 416 TownsendR.DietzA.HaleC.AkhtarS.KowalskiD.LademacherC.et al
Nat Neurosci 9:119126 Shashidharan P, Huntley GW, Murray JM, Buku A, Moran T, Walsh MJ, Morrison JH, Plaitakis A (1997) Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody
This preserves the stability of both ingredients
The answer might depend on the individual, their age or health status, or what they are using the drug for
In 2014, LaRocca et al